DocWire News Editors

DocwireNews

<p>For patients with psoriatic arthritis (PsA) optimal improvements in their health-related quality of life (HRQol) are dependent on successfully treating both joint and skin symptoms, according to recent findings. In this study, researchers randomly allocated patients to receive ixekizumab, an interleukin-17A antagonist, or a placebo. Some of the study outcomes included Disease Activity Index for Psoriatic Arthritis (DAPSA), Psoriasis Area and Severity Index (PASI) and the European Quality of Life-Five Dimensions (EQ-5D) Visual Analogue Score (VAS). Subsequent to modelling the contribution of joint and skin improvements to HRQoL using a smoothing spline method, the results indicated the highest improvement in EQ-5D VAS correlate with the most improvements in both DAPSA and PASI together.<p>Read more: <a href="https://ard.bmj.com/content/early/2019/05/21/annrheumdis-2018-215003">https://ard.bmj.com/content/early/2019/05/21/annrheumdis-2018-215003</a></p></p>


Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

The Contribution of Joint and Skin Improvements to the Health-Related Quality of Life of Patients with Psoriatic Arthritis

Orthopedics

For patients with psoriatic arthritis (PsA) optimal improvements in their health-related quality of life (HRQol) are dependent on successfully treating both joint and skin ...

The Contribution of Joint and Skin Improvements to the Health-Related Quality of Life of Patients

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe